SMS Pharmaceuticals

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue163.00337.70121.2560.9264.39
Expenses126.56262.29102.3073.1073.13
EBITDA36.4475.4118.95-12.18-8.74
EBIT28.4459.3310.85-20.15-16.67
Profit Before Tax32.7768.2716.33-16.09-12.79
Net Profit23.5646.858.966.41-12.77
Financial Ratios
Operating Profit Margin22.36%22.33%15.63%-19.99%-13.57%
Net Profit Margin14.45%13.87%7.39%10.52%-19.83%
Earning Per Share (Diluted)2.785.561.070.76-1.51
Dividends Per ShareNANANA0.30NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI